Johannes Kornhuber Selected Research

Guanine Nucleotide-Releasing Factor 2

10/2014	Rasgrf2 controls noradrenergic involvement in the acute and subchronic effects of alcohol in the brain.
10/2014	Rasgrf2 controls dopaminergic adaptations to alcohol in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Kornhuber Research Topics

Disease

100	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2003
65	Alcoholism (Alcohol Abuse) 03/2022 - 05/2004
59	Dementia (Dementias) 01/2022 - 01/2003
38	Cognitive Dysfunction 01/2022 - 11/2005
15	Schizophrenia (Dementia Praecox) 01/2021 - 08/2003
12	Mental Disorders (Mental Disorder) 01/2022 - 09/2003
12	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 11/2009
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2004
10	Atrophy 11/2017 - 04/2003
8	Infections 01/2022 - 01/2014
8	Seizures (Absence Seizure) 01/2016 - 11/2004
8	Alcohol Withdrawal Seizures 01/2012 - 05/2004
7	Substance-Related Disorders (Drug Abuse) 01/2021 - 09/2012
7	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 10/2008
7	Feeding and Eating Disorders (Eating Disorder) 12/2012 - 10/2006
6	Disease Progression 01/2022 - 02/2015
6	COVID-19 01/2022 - 11/2020
6	Amyloid Plaque 01/2018 - 05/2006
6	Bulimia Nervosa 12/2012 - 01/2008
5	Mood Disorders (Mood Disorder) 01/2022 - 07/2013
5	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2021 - 01/2011
5	Inflammation (Inflammations) 01/2021 - 01/2014
5	Neoplasms (Cancer) 01/2018 - 01/2014
5	Anorexia Nervosa 12/2012 - 01/2008
4	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 12/2004
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2006
4	Pain (Aches) 05/2020 - 11/2004
4	Niemann-Pick Diseases (Niemann Pick Disease) 01/2019 - 01/2013
4	Depressive Disorder (Melancholia) 04/2014 - 04/2010
4	Tobacco Use Disorder (Nicotine Dependence) 11/2012 - 03/2010
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 04/2008
3	Vesicular Stomatitis 01/2021 - 11/2020
3	Virus Diseases (Viral Diseases) 11/2020 - 07/2012
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2018
3	Primary Progressive Aphasia 01/2018 - 01/2011
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018 - 04/2011
3	Body Weight (Weight, Body) 01/2013 - 06/2011
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2005 - 12/2003
2	Multiple Sclerosis 01/2021 - 01/2018
2	Genetic Risk Score 01/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

82	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2004
33	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
30	Amyloid beta-PeptidesIBA 01/2022 - 01/2003
28	HomocysteineIBA 12/2018 - 04/2003
26	Peptides (Polypeptides)IBA 01/2021 - 01/2003
22	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 03/2022 - 01/2010
21	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2004
20	AcidsIBA 01/2022 - 01/2010
17	CeramidesIBA 01/2022 - 11/2009
15	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2007
14	Antidepressive Agents (Antidepressants)IBA 01/2022 - 07/2006
13	EnzymesIBA 01/2021 - 07/2004
10	Messenger RNA (mRNA)IBA 12/2012 - 12/2004
9	LipidsIBA 01/2022 - 10/2011
9	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 08/2003
8	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 01/2012
8	ApolipoproteinsIBA 01/2020 - 11/2007
8	tau Proteins (tau Protein)IBA 01/2018 - 01/2004
7	SphingolipidsIBA 01/2022 - 01/2014
7	LeptinIBA 01/2021 - 12/2005
7	alpha-SynucleinIBA 04/2019 - 12/2004
6	CytokinesIBA 01/2018 - 02/2012
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017 - 04/2010
5	Apolipoprotein E4IBA 01/2022 - 11/2005
5	AndrogensIBA 01/2021 - 08/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2004
5	Testosterone (Sustanon)FDA Link 01/2021 - 05/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2012
5	Biological ProductsIBA 01/2019 - 01/2003
4	Nerve Growth Factor (NGF)IBA 01/2019 - 08/2008
4	DNA (Deoxyribonucleic Acid)IBA 03/2015 - 02/2005
4	CholesterolIBA 07/2014 - 11/2010
4	Androgen Receptors (Androgen Receptor)IBA 05/2014 - 03/2011
4	ProlactinIBA 02/2011 - 01/2006
3	N-Methylaspartate (NMDA)IBA 01/2022 - 05/2004
3	Fluoxetine (Prozac)FDA LinkGeneric 01/2022 - 08/2010
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 11/2018
3	Amitriptyline (Elavil)FDA LinkGeneric 01/2021 - 01/2016
3	Heroin (Diamorphine)IBA 01/2021 - 01/2012
3	SARS-CoV-2 spike proteinIBA 01/2021 - 11/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2010
3	Blood Alcohol ContentIBA 12/2018 - 03/2005
3	Urea (Carbamide)FDA LinkGeneric 01/2018 - 09/2004
3	EndocannabinoidsIBA 01/2017 - 05/2009
3	Hormones (Hormone)IBA 05/2016 - 12/2007
3	Memantine (Namenda)FDA Link 11/2015 - 08/2003
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 05/2014 - 12/2007
3	Glutamic Acid (Glutamate)FDA Link 07/2012 - 09/2003
3	OrexinsIBA 01/2012 - 06/2011
3	hydrogen sulfite (bisulfite)IBA 09/2011 - 04/2010
3	GhrelinIBA 01/2009 - 12/2005
2	AntibodiesIBA 01/2022 - 04/2012
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 01/2009
2	Leptin ReceptorsIBA 01/2021 - 01/2020
2	SynucleinsIBA 01/2021 - 02/2013

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2003
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
4	Activities of Daily Living (ADL) 01/2020 - 02/2009
3	Transcranial Magnetic Stimulation 03/2016 - 11/2004
3	Vagus Nerve Stimulation 09/2013 - 06/2010